Skip to navigation Skip to content
  • Woodruff
  • Business
  • Health Sciences
  • Law
  • MARBL
  • Oxford College
  • Theology
  • Schools
    • Undergraduate

      • Emory College
      • Oxford College
      • Business School
      • School of Nursing

      Community

      • Emory College
      • Oxford College
      • Business School
      • School of Nursing
    • Graduate

      • Business School
      • Graduate School
      • School of Law
      • School of Medicine
      • School of Nursing
      • School of Public Health
      • School of Theology
  • Libraries
    • Libraries

      • Robert W. Woodruff
      • Business
      • Chemistry
      • Health Sciences
      • Law
      • MARBL
      • Music & Media
      • Oxford College
      • Theology
    • Library Tools

      • Course Reserves
      • Databases
      • Digital Scholarship (ECDS)
      • discoverE
      • eJournals
      • Electronic Dissertations
      • EmoryFindingAids
      • EUCLID
      • ILLiad
      • OpenEmory
      • Research Guides
  • Resources
    • Resources

      • Administrative Offices
      • Emory Healthcare
      • Academic Calendars
      • Bookstore
      • Campus Maps
      • Shuttles and Parking
      • Athletics: Emory Eagles
      • Arts at Emory
      • Michael C. Carlos Museum
      • Emory News Center
      • Emory Report
    • Resources

      • Emergency Contacts
      • Information Technology (IT)
      • Outlook Web Access
      • Office 365
      • Blackboard
      • OPUS
      • PeopleSoft Financials: Compass
      • Careers
      • Human Resources
      • Emory Alumni Association
  • Browse
    • Works by Author
    • Works by Journal
    • Works by Subject
    • Works by Dept
    • Faculty by Dept
  • For Authors
    • How to Submit
    • Deposit Advice
    • Author Rights
    • Publishing Your Data
    • FAQ
    • Emory Open Access Policy
    • Open Access Fund
  • About OpenEmory
    • About OpenEmory
    • About Us
    • Citing Articles
    • Contact Us
    • Privacy Policy
    • Terms of Use
 
Contact Us

Filter Results:

Year

  • 2018 (1)

Author

  • Adhami, Talal (1)
  • Al-Khafaji, Ali (1)
  • Ashley, Robert (1)
  • Asrani, Sumeet (1)
  • Bedard, Patricia (1)
  • Borg, Brian (1)
  • Brown, Robert (1)
  • Colquhoun, Steven (1)
  • Duarte-Rojo, Andres (1)
  • Duddempudi, Anupama (1)
  • ElSharkawy, Ahmed (1)
  • Frank, William (1)
  • Gaglio, Paul (1)
  • Habib, Shahid (1)
  • Hart, Marquis (1)
  • Hassanein, Tarek (1)
  • Henry, Alyssa (1)
  • Henry, Andrew (1)
  • Jalan, Rajiv (1)
  • Jones, Natasha (1)
  • Landeen, Lee (1)
  • Landis, Charles (1)
  • MacNicholas, Ross (1)
  • Malik, Raza (1)
  • Malik, Shahid (1)
  • Mantry, Parvez (1)
  • McCaughan, Geoffrey (1)
  • Millis, Michael (1)
  • Munoz, Santiago (1)
  • Parikh, Amay (1)
  • Patton, Heather (1)
  • Reich, David (1)
  • Satoskar, Rohit (1)
  • Shah, Nikunj (1)
  • Sher, Linda (1)
  • Stange, Jan (1)
  • Stein, Lance (1)
  • Subramanian, Ram (1)
  • Teperman, Lewis (1)
  • Thompson, Julie (1)
  • Wigg, Alan (1)
  • Wolf, David (1)

Subject

  • Health Sciences, Medicine and Surgery (1)

Journal

  • Liver Transplantation (1)

Keyword

  • 3 (1)
  • a (1)
  • biomedicin (1)
  • c (1)
  • cell (1)
  • clinicaltri (1)
  • diseas (1)
  • gastroenterolog (1)
  • hepatolog (1)
  • life (1)
  • liver (1)
  • liverdiseas (1)
  • mortal (1)
  • pentoxifyllin (1)
  • prednisolon (1)
  • scienc (1)
  • strategi (1)
  • surgeri (1)
  • technolog (1)
  • transplant (1)
  • trial (1)

Author department

  • Medicine: Digestive Dis (1)

Search Results for all work with filters:

  • Rossi, Simona
  • Health Sciences, General
  • t
  • failur
  • clinic

Work 1 of 1

Sorted by relevance

Article

Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial

by Julie Thompson; Natasha Jones; Ali Al-Khafaji; Shahid Malik; David Reich; Santiago Munoz; Ross MacNicholas; Tarek Hassanein; Lewis Teperman; Lance Stein; Andres Duarte-Rojo; Raza Malik; Talal Adhami; Sumeet Asrani; Nikunj Shah; Paul Gaglio; Anupama Duddempudi; Brian Borg; Rajiv Jalan; Robert Brown; Heather Patton; Rohit Satoskar; Simona Rossi; Amay Parikh; Ahmed ElSharkawy; Parvez Mantry; Linda Sher; David Wolf; Marquis Hart; Charles Landis; Alan Wigg; Shahid Habib; Geoffrey McCaughan; Steven Colquhoun; Alyssa Henry; Patricia Bedard; Lee Landeen; Michael Millis; Robert Ashley; William Frank; Andrew Henry; Jan Stange; Ram Subramanian

2018

Subjects
  • Health Sciences, Medicine and Surgery
  • Health Sciences, General
  • File Download
  • View Abstract

Abstract:Close

Liver Transplantation published by Wiley Periodicals, Inc. on behalf of American Association for the Study of Liver Diseases. Severe alcoholic hepatitis (sAH) is associated with a poor prognosis. There is no proven effective treatment for sAH, which is why early transplantation has been increasingly discussed. Hepatoblastoma-derived C3A cells express anti-inflammatory proteins and growth factors and were tested in an extracorporeal cellular therapy (ELAD) study to establish their effect on survival for subjects with sAH. Adults with sAH, bilirubin ≥8 mg/dL, Maddrey's discriminant function ≥ 32, and Model for End-Stage Liver Disease (MELD) score ≤ 35 were randomized to receive standard of care (SOC) only or 3-5 days of continuous ELAD treatment plus SOC. After a minimum follow-up of 91 days, overall survival (OS) was assessed by using a Kaplan-Meier survival analysis. A total of 203 subjects were enrolled (96 ELAD and 107 SOC) at 40 sites worldwide. Comparison of baseline characteristics showed no significant differences between groups and within subgroups. There was no significant difference in serious adverse events between the 2 groups. In an analysis of the intent-to-treat population, there was no difference in OS (51.0% versus 49.5%). The study failed its primary and secondary end point in a population with sAH and with a MELD ranging from 18 to 35 and no upper age limit. In the prespecified analysis of subjects with MELD < 28 (n = 120), ELAD was associated with a trend toward higher OS at 91 days (68.6% versus 53.6%; P =.08). Regression analysis identified high creatinine and international normalized ratio, but not bilirubin, as the MELD components predicting negative outcomes with ELAD. A new trial investigating a potential benefit of ELAD in younger subjects with sufficient renal function and less severe coagulopathy has been initiated. Liver Transplantation 24 380–393 2018 AASLD.
Site Statistics
  • 16,857
  • Total Works
  • 3,648,323
  • Downloads
  • 1,124,234
  • Downloads This Year
  • 6,807
  • Faculty Profiles

Copyright © 2016 Emory University - All Rights Reserved
540 Asbury Circle, Atlanta, GA 30322-2870
(404) 727-6861
Privacy Policy | Terms & Conditions

v2.2.8-dev

Contact Us Recent and Popular Items
Download now